They found that enhanced CD8 T-cell exhaustion and reduced CD4 T-cell co-stimulation gene signatures indicated a better prognosis in SLE and AAV patients. This evidence concerns the gene CD8A and anti-neutrophil cytoplasmic antibody-associated vasculitis.